Related Experiment Videos
Fibronectin in fulminant hepatic failure
Abstract:
Thirteen out of 17 patients with fulminant hepatic failure had plasma fibronectin concentrations below the normal range (194--472 micrograms/ml), the mean concentration in all 17 patients being 117.9 +/- SE 19.4 micrograms/ml. There was a significant negative correlation between plasma fibronectin concentration and aspartate aminotransferase activity, suggesting that fibronectin is consumed during clearance of hepatocyte debris. The reduced availability of fibronectin may be an important factor in the impaired function of Kuppfer cells in patients with fulminant hepatic failure.
Insights
Fulminant hepatic failure patients often show low plasma fibronectin levels. This reduction may impair Kupffer cell function, impacting liver health.
Area of Science:
- Hepatology
- Immunology
Background:
- Fulminant hepatic failure (FHF) is a severe clinical syndrome.
- Kupffer cells play a crucial role in liver immune surveillance and debris clearance.
Purpose of the Study:
- To investigate plasma fibronectin concentrations in patients with FHF.
- To explore the relationship between fibronectin levels, liver injury markers, and Kupffer cell function.
Main Methods:
- Measurement of plasma fibronectin concentrations in 17 FHF patients.
- Correlation analysis between fibronectin levels and aspartate aminotransferase (AST) activity.
Main Results:
- 13 out of 17 FHF patients had below-normal plasma fibronectin (<194–472 µg/ml).
- Mean fibronectin concentration was significantly reduced (117.9 ± 19.4 µg/ml).
- A negative correlation was observed between fibronectin and AST, suggesting fibronectin consumption.
Conclusions:
- Reduced plasma fibronectin is common in FHF.
- Fibronectin consumption may occur during hepatocyte debris clearance.
- Low fibronectin availability could contribute to impaired Kupffer cell function in FHF.